Barbara Klencke
2016
In 2016, Barbara Klencke earned a total compensation of $1.5M as Chief Development Officer at ProNAi Therapeutics, a 76% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,950 |
|---|---|
| Option Awards | $941,160 |
| Salary | $420,000 |
| Other | $2,650 |
| Total | $1,488,760 |
Klencke received $941.2K in option awards, accounting for 63% of the total pay in 2016.
Klencke also received $125K in non-equity incentive plan, $420K in salary and $2.7K in other compensation.
Rankings
In 2016, Barbara Klencke's compensation ranked 6,283rd out of 14,075 executives tracked by ExecPay. In other words, Klencke earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,283 out of 14,075 | 55th |
Division Manufacturing | 2,309 out of 5,489 | 58th |
Major group Chemicals And Allied Products | 757 out of 1,895 | 60th |
Industry group Drugs | 573 out of 1,538 | 63rd |
Industry Pharmaceutical Preparations | 451 out of 1,176 | 62nd |
Source: SEC filing on April 25, 2017.
Klencke's colleagues
We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2016.